[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:atherosclerosis":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":295,"states":304},"Atherosclerosis",47,40,[8,16,23,29,35,41,47,53,59,65,71,77,83,89,95,101,107,114,119,125,131,137,143,149,155,161,167,173,179,185,191,197,203,209,215,221,226,233,239,244,250,257,263,269,275,282,289],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07327840","Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)",[12],"Phase 2","RECRUITING","2026-08-26T02:16:50.548894Z","2026-07-05T03:45:20.248611Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07613294","A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk",[20],"Phase 3","2026-08-26T02:17:32.059863Z","2026-05-29T15:36:40.232635Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07448038","A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events",[12],"2026-08-26T02:17:48.768272Z","2026-05-05T02:43:29.535381Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT04505865","The Effect of Mindfulness on Vascular Inflammation in Stable Coronary Disease",[],"2026-08-26T02:19:22.562392Z","2026-05-05T02:43:29.496577Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT07157774","Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)",[20],"2026-08-26T02:18:01.700186Z","2026-05-05T02:43:29.323863Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT06813911","Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD",[20],"2026-08-26T02:15:54.846520Z","2026-05-05T02:43:28.963810Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT07303777","Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis",[12],"2026-08-26T02:16:40.941792Z","2026-05-05T02:43:28.644700Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":57,"content_modified":58},"NCT07260032","Determining the Benefits of Exercise on Cardiovascular Risk in PTSD",[],"2026-08-26T02:16:49.565137Z","2026-05-05T02:43:27.602959Z",{"nct_id":60,"title":61,"phases":62,"status":13,"updated_at":63,"content_modified":64},"NCT07293260","Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial",[20],"2026-08-26T02:17:30.145302Z","2026-05-05T02:43:27.391426Z",{"nct_id":66,"title":67,"phases":68,"status":13,"updated_at":69,"content_modified":70},"NCT06875973","Pelacarsen Roll-over Extension Program",[20],"2026-08-26T02:17:02.694423Z","2026-05-05T02:43:27.095908Z",{"nct_id":72,"title":73,"phases":74,"status":13,"updated_at":75,"content_modified":76},"NCT07000357","A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event",[20],"2026-08-26T02:15:53.461103Z","2026-05-05T02:35:31.760630Z",{"nct_id":78,"title":79,"phases":80,"status":13,"updated_at":81,"content_modified":82},"NCT06691217","Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis",[12],"2026-08-26T02:15:00.557154Z","2026-07-05T05:32:16.768451Z",{"nct_id":84,"title":85,"phases":86,"status":13,"updated_at":87,"content_modified":88},"NCT05488431","Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)",[12],"2026-08-26T02:19:07.104270Z","2026-05-05T02:43:28.714261Z",{"nct_id":90,"title":91,"phases":92,"status":13,"updated_at":93,"content_modified":94},"NCT07037433","Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity",[20],"2026-08-26T02:19:02.550788Z","2026-05-05T02:43:27.394200Z",{"nct_id":96,"title":97,"phases":98,"status":13,"updated_at":99,"content_modified":100},"NCT07334834","Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic Cardiovascular Disease",[],"2026-08-26T02:15:22.311223Z","2026-05-05T02:43:26.984643Z",{"nct_id":102,"title":103,"phases":104,"status":13,"updated_at":105,"content_modified":106},"NCT05867381","Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History",[],"2026-08-26T02:15:03.757872Z","2026-05-05T02:43:29.073109Z",{"nct_id":108,"title":109,"phases":110,"status":13,"updated_at":112,"content_modified":113},"NCT05390892","PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes",[111],"Phase 4","2026-08-26T02:15:46.655893Z","2026-05-05T02:43:28.282145Z",{"nct_id":115,"title":116,"phases":117,"status":13,"updated_at":33,"content_modified":118},"NCT06494501","The Prevent Coronary Artery Disease Trial",[20],"2026-05-05T02:43:27.744105Z",{"nct_id":120,"title":121,"phases":122,"status":13,"updated_at":123,"content_modified":124},"NCT06471036","Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients?",[],"2026-08-26T02:16:36.513735Z","2026-05-05T02:43:27.265239Z",{"nct_id":126,"title":127,"phases":128,"status":13,"updated_at":129,"content_modified":130},"NCT06488105","Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial",[12],"2026-08-26T02:16:00.194860Z","2026-04-29T02:57:57.066630Z",{"nct_id":132,"title":133,"phases":134,"status":13,"updated_at":135,"content_modified":136},"NCT05642858","Text Education About Cardiovascular Health and HIV (TEACH-HIV)",[],"2026-08-26T02:16:33.772093Z","2026-04-29T02:57:57.118288Z",{"nct_id":138,"title":139,"phases":140,"status":13,"updated_at":141,"content_modified":142},"NCT07226193","Detecting Peripheral Artery Disease With the Pulse",[],"2026-08-26T02:16:13.426928Z","2026-05-05T02:43:27.602916Z",{"nct_id":144,"title":145,"phases":146,"status":13,"updated_at":147,"content_modified":148},"NCT07464574","Optimizing Non-statin Agents for ASCVD",[],"2026-08-26T02:18:23.582895Z","2026-05-13T02:55:06.706955Z",{"nct_id":150,"title":151,"phases":152,"status":13,"updated_at":153,"content_modified":154},"NCT07315997","The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study",[],"2026-08-26T02:17:20.511551Z","2026-05-13T02:55:06.686915Z",{"nct_id":156,"title":157,"phases":158,"status":13,"updated_at":159,"content_modified":160},"NCT06808334","CLAiR Pivotal Study",[],"2026-08-26T02:17:30.961790Z","2026-05-13T02:55:06.580187Z",{"nct_id":162,"title":163,"phases":164,"status":13,"updated_at":165,"content_modified":166},"NCT06676046","Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic Conditions",[],"2026-08-26T02:17:15.156099Z","2026-05-13T02:55:06.561364Z",{"nct_id":168,"title":169,"phases":170,"status":13,"updated_at":171,"content_modified":172},"NCT07704918","Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma",[],"2026-08-26T02:17:38.215063Z","2026-07-19T19:36:05.087029Z",{"nct_id":174,"title":175,"phases":176,"status":13,"updated_at":177,"content_modified":178},"NCT02932176","Machine Learning for Handheld Vascular Studies",[],"2026-08-26T02:17:33.807405Z","2026-05-13T02:55:06.102895Z",{"nct_id":180,"title":181,"phases":182,"status":13,"updated_at":183,"content_modified":184},"NCT00353782","Causes and Natural History of Dyslipidemias",[],"2026-08-26T02:17:29.353236Z","2026-05-13T02:55:06.034953Z",{"nct_id":186,"title":187,"phases":188,"status":13,"updated_at":189,"content_modified":190},"NCT03581318","Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging",[],"2026-08-26T02:16:01.910993Z","2026-07-30T01:46:14.463068Z",{"nct_id":192,"title":193,"phases":194,"status":13,"updated_at":195,"content_modified":196},"NCT01143454","Characterization of Patients With Uncommon Presentations and\u002For Uncommon Diseases Associated With the Cardiovascular System",[],"2026-08-26T02:17:51.502023Z","2026-05-13T02:55:06.068011Z",{"nct_id":198,"title":199,"phases":200,"status":13,"updated_at":201,"content_modified":202},"NCT04496947","Pilot Study Evaluating the Impact of Stress Reduction on Atherosclerotic : Heart and Mind Study",[],"2026-08-26T02:16:59.895916Z","2026-05-05T02:43:29.229032Z",{"nct_id":204,"title":205,"phases":206,"status":13,"updated_at":207,"content_modified":208},"NCT07121010","How Animal and Plant Protein Shakes Change the Body's Nutrient and Health Responses",[],"2026-08-26T02:18:24.494016Z","2026-05-05T02:43:29.165722Z",{"nct_id":210,"title":211,"phases":212,"status":13,"updated_at":213,"content_modified":214},"NCT06571162","A Pragmatic INitiative for LDL-C Management by a CLinical Pharmacist-Led Team Among Atherosclerotic CardiovascUlar DisEase Patients",[],"2026-08-26T02:16:15.345907Z","2026-05-05T02:43:27.660568Z",{"nct_id":216,"title":217,"phases":218,"status":13,"updated_at":219,"content_modified":220},"NCT05708859","Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT",[111],"2026-08-26T02:16:27.227548Z","2026-05-05T02:43:27.605069Z",{"nct_id":222,"title":223,"phases":224,"status":13,"updated_at":45,"content_modified":225},"NCT05235464","High Protein Diet and Atherosclerosis",[],"2026-05-05T02:43:27.104973Z",{"nct_id":227,"title":228,"phases":229,"status":13,"updated_at":231,"content_modified":232},"NCT05485961","Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)",[230],"Phase 2\u002FPhase 3","2026-08-26T02:17:00.709807Z","2026-07-19T19:36:05.116191Z",{"nct_id":234,"title":235,"phases":236,"status":13,"updated_at":237,"content_modified":238},"NCT06568601","Pharmacogenomic Informed Statin Prescribing",[],"2026-08-26T02:17:57.997171Z","2026-05-05T02:43:28.793060Z",{"nct_id":240,"title":241,"phases":242,"status":13,"updated_at":237,"content_modified":243},"NCT01399385","New Heart Imaging Techniques to Evaluate Possible Heart Disease",[],"2026-05-05T02:43:29.469290Z",{"nct_id":245,"title":246,"phases":247,"status":13,"updated_at":248,"content_modified":249},"NCT06587204","Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health",[],"2026-08-26T02:16:48.735701Z","2026-05-05T02:43:26.896831Z",{"nct_id":251,"title":252,"phases":253,"status":254,"updated_at":255,"content_modified":256},"NCT07654231","Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD",[12],"NOT_YET_RECRUITING","2026-08-26T02:16:55.892527Z","2026-07-05T05:32:16.643674Z",{"nct_id":258,"title":259,"phases":260,"status":254,"updated_at":261,"content_modified":262},"NCT07594392","Clinical Assessment and Targeted Imaging to Characterize High-Risk Atherosclerotic Cardiovascular Disease of Survivors in SJLIFE",[],"2026-08-26T02:18:31.944757Z","2026-05-29T15:36:40.204157Z",{"nct_id":264,"title":265,"phases":266,"status":254,"updated_at":267,"content_modified":268},"NCT07355894","Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD)",[],"2026-08-26T02:15:25.633039Z","2026-05-05T02:43:27.337753Z",{"nct_id":270,"title":271,"phases":272,"status":254,"updated_at":273,"content_modified":274},"NCT07117695","Duke Cardiometabolic Prevention Clinic's Impact on High-risk Cardiovascular Patients With Uncontrolled Risk Factors",[],"2026-08-26T02:18:49.989941Z","2026-05-05T02:43:28.018613Z",{"nct_id":276,"title":277,"phases":278,"status":279,"updated_at":280,"content_modified":281},"NCT06960655","Improving Lipid Optimization Quality and Treatment Options in ASCVD",[],"ENROLLING_BY_INVITATION","2026-08-26T02:16:52.995882Z","2026-06-16T05:54:07.844031Z",{"nct_id":283,"title":284,"phases":285,"status":286,"updated_at":287,"content_modified":288},"NCT07235046","A Study of DII235 in Adults With Elevated Lipoprotein(a)",[12],"ACTIVE_NOT_RECRUITING","2026-08-03T02:07:36.529363Z","2026-05-05T02:43:28.222408Z",{"nct_id":290,"title":291,"phases":292,"status":286,"updated_at":293,"content_modified":294},"NCT07522645","Adherence to Dyslipidemia Therapy: Harnessing Evidence From Randomized Evaluations in AtheroSclerotic CardioVascular Disease",[],"2026-08-03T02:28:08.200434Z","2026-05-05T02:43:28.711050Z",[296,300],{"biomarker":297,"count":298,"slug":299},"Apolipoprotein(a)",5,"apolipoprotein-a",{"biomarker":301,"count":302,"slug":303},"COMPONENT OF OLIGOMERIC GOLGI COMPLEX 2",4,"component-of-oligomeric-golgi-complex-2",[305,309,313,317,320,323,327,331,335,339,342,345,349,352,355,358,361,365,368,371,374,378,381,384],{"state":306,"count":307,"slug":308},"California",18,"california",{"state":310,"count":311,"slug":312},"Texas",14,"texas",{"state":314,"count":315,"slug":316},"Florida",13,"florida",{"state":318,"count":315,"slug":319},"Maryland","maryland",{"state":321,"count":315,"slug":322},"North Carolina","north-carolina",{"state":324,"count":325,"slug":326},"Massachusetts",12,"massachusetts",{"state":328,"count":329,"slug":330},"Pennsylvania",11,"pennsylvania",{"state":332,"count":333,"slug":334},"Tennessee",10,"tennessee",{"state":336,"count":337,"slug":338},"Michigan",9,"michigan",{"state":340,"count":337,"slug":341},"Nevada","nevada",{"state":343,"count":337,"slug":344},"Virginia","virginia",{"state":346,"count":347,"slug":348},"Alabama",8,"alabama",{"state":350,"count":347,"slug":351},"Georgia","georgia",{"state":353,"count":347,"slug":354},"Louisiana","louisiana",{"state":356,"count":347,"slug":357},"New York","new-york",{"state":359,"count":347,"slug":360},"Ohio","ohio",{"state":362,"count":363,"slug":364},"Illinois",7,"illinois",{"state":366,"count":363,"slug":367},"Indiana","indiana",{"state":369,"count":363,"slug":370},"Utah","utah",{"state":372,"count":363,"slug":373},"Washington","washington",{"state":375,"count":376,"slug":377},"Arizona",6,"arizona",{"state":379,"count":376,"slug":380},"Kansas","kansas",{"state":382,"count":376,"slug":383},"Missouri","missouri",{"state":385,"count":376,"slug":386},"New Jersey","new-jersey"]